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In the presence of glutamate and co-agonists, e.g., glycine, the N-methyl-D-aspartate receptor (NMDAR) plays an important 
role in physiological and pathophysiological brain processes. Previous studies indicate glycine could inhibit NMDAR respons-
es induced by high concentration of NMDA in hippocampal neurons. The mechanism underlying this inhibitory impact, how-
ever, has been unclear. In this study, the whole-cell patch-clamp recording and Ca2+ imaging with Fluo-3/AM under laser 
scanning confocal microscope were used to analyze the possible involvement of NMDAR subunits in this effect. We found 
that the peak current of NMDARs and Ca2+ influx induced by high concentration of NMDA were reduced by treatment of gly-
cine (0.03–10 mol L1) in a dose-dependent manner, and that the glycine-dependent inhibition of NMDAR responses, which 
were induced at 300 mol L1 NMDA, was reversed by ZnCl2 through the blocking of the NR2A subunit of NMDARs, but 
was less influenced by ifenprodil, a NR2B inhibitor. Our results suggest that the glycine-dependent inactivation of NMDARs is 
potentially modulated by the regulatory subunit NR2A. 
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N-methyl-D-aspartate receptor (NMDAR) ion channels are 
generally considered as postsynaptic targets of gluta-
mate-mediated synaptic transmission in the central nervous 
system. NMDARs play critical roles in physiological pro-
cesses such as synaptic plasticity and memory by allowing 
glutamate-gated calcium influx into neuronal cells [1]. A 
property of the NMDARs is its voltage-dependent activation, 
a result of ion channel block by extracellular Mg2+ ions, 
which allows the flow of Na+ and small amounts of Ca2+ ions 
into the cell and K+ out of the cell [2]. Besides, the 
NMDAR requires co-activation of the glycine site located 
on its NR1 subunit by D-serine or glycine in addition to the 
synaptically released neurotransmitter glutamate [3,4]. 
However, the mechanistic connection between glutamate 
and glycine binding in the modulation of NMDAR activa-
tion and inactivation is unclear. 
Many mechanisms have been proposed to account for the 
mediation of the inactivation of NMDARs, including gly-
cine-dependent desensitization, glycine-independent desen-
sitization [5,6], Ca2+-dependent inactivation [7–9] and sur-
face membrane receptors internalization [10]. Activation of 
NMDARs that have been pre-equilibrated with glycine 
produces a peak current, which decays or desensitizes to a 
steady-state level at high concentrations of NMDA. Ac-
cording to the desensitization of currents in the presence of 
saturation concentrations of glutamate and glycine agonists, 
two types of desensitization, glycine-independent or gly-
cine-dependent, have been characterized for NMDARs. 
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Magnitude of glycine-independent desensitization and cal-
cium dependent inactivation are controlled by the key resi-
dues in the NR2 subunit [11]. The degree of desensitization 
is inversely dependent on the saturation degree of the gly-
cine binding site and results from a weakening of glycine 
affinity upon channel activation [6,12]. The mechanisms 
underlying desensitization or inactivation of NMDAR are 
complicated. Nong et al. [10] raise the possibility that 
NMDARs may undergo regulated transport to and from the 
cell surface. We previously proposed a new mechanism of 
glycine-dependent inactivation, which occurred when 
NMDARs were activated by high concentrations of NMDA 
(optimal 300 mol L1) via activation of the glycine binding 
site of NMDARs but not activation of the strychnine-sensi-      
tive glycine-receptor-gated chloride channel [13]. The in-
hibitory influence of glycine on NMDARs provides a new 
insight into the complexity of neuronal feedback loops and 
synaptic transmission.  
However, the NMDAR forms a heterotetramer between 
two NR1 and two NR2 subunits [14,15], whether NR2 sub-
units of NMDARs are associated with the glycine-dependent 
inactivation and contribute to the inhibition of glycine affin-
ity or not is to be answered. The purpose of this study was 
to investigate whether and how the inhibitors of NR2A or 
NR2B, i.e., zinc or ifenprodil, influenced glycine-dependent 
inactivation in cultured hippocampal neurons. 
1  Materials and methods 
1.1  Animals and chemicals 
Sprague-Dawley rats were obtained from the Experimental 
Animal Center of Nantong University, Jiangsu, China. All 
procedures used in this study were in accordance with our 
institutional guidelines, which comply with international 
rules and policies. Common inorganic salts were purchased 
in China, chemicals for neuronal culture were products of 
GIBCO (Invitrogen Corporation, Carlsbad, USA), Fluo3-AM 
from Dojindo Laboratories (Kumamoto, Japan), other 
chemicals except those indicated elsewhere were purchased 
from Sigma-Aldrich Corporation (Saint Louis, USA). 
1.2  Cell culture 
The procedure for producing low-density rat hippocampal 
neuronal cultures was according to Stefanie detailed previ-
ously [16]. Briefly, the hippocampi were isolated from the 
embryonic (E17–18) rats, cut into pieces, and digested with 
0.125% trypsin at 37°C for 12 min. The digested brain tis-
sue pieces were mildly triturated to a single-cell suspension, 
and plated at a density of 75000 cells mL1 on to coverslips 
(1 cm×1 cm) coated with poly-L-lysine overnight at 4°C 
prior to the experiment. The day of plating was counted as 
day-in-vitro (DIV) 0. The feeding medium was changed 
every 3 days. Cultures were maintained in a humidified air 
conditioning 5% CO2 at 37°C. The cultured hippocampal 
neurons on DIV 11-12 were used for following experi-
ments.  
1.3  Whole-cell recording of NMDA-activated currents 
Whole-cell voltage clamp experiments were conducted uti-
lizing an MultiClamp 700A amplifier (Axon Instruments, 
Foster City, CA) at room temperature on DIV11-12 neurons. 
The extracellular control solution consisted of (in mmol 
L1): NaCl 150, KCl 3, HEPES 10, CaCl2∙2H2O 3, Glucose 
8 (pH 7.4 adjusted with 1 mol L1 NaOH, and osmolarity 
300310 mOsm adjusted with sucrose). NMDA was dis-
solved in bath solution immediately before use. INMDA was 
recorded via a glass microelectrode filled with pipette solu-
tion containing (in mmol L1): CH3O3SCs 135, NaCl 8, 
HEPES 10, EGTA 0.5, Mg-ATP 4, and Na-GTP 0.3, ad-
justed to pH 7.2 and 305 mOsm. Being filled with pipette 
solution, the microelectrode had a resistance of 58 MΩ. 
The junction potential between microelectrode pipette and 
bath solution was 9.9 mV. This value was calculated using 
the junction potential calculation system of Clampex 8.0 of 
pCLAMP 8.0, and nulled just before forming giga-seal. In 
most experiments, series resistance (Rs) before compensa-
tion was 10–20 MΩ. Routinely, 70%–80% of the Rs were 
compensated. Only neurons with Rs less than 20 MΩ were 
selected for further tests. All NMDA currents were recorded 
while membrane potential was held at 70 mV. 
To observe the influence of glycine and other agents on 
INMDA, NMDA, glycine and other agents were all dissolved 
in bath solution and applied to each neuron via a rapid drug 
perfusion apparatus (DAD-8VC, ALA Scientific Instrument 
Inc., New York, USA). This perfusion system applies pres-
surized injection, and allows complete exchange of solutions 
in the vicinity of neuron with dead volume less than 1 μL and 
without cross contamination and loss of mechanical stability. 
The tip (100 m inner diameter) of micromanifold was 
usually placed 50–100 m away from the cell recorded. The 
bath was continuously perfused with normal bath solution 
throughout all experimental procedures except application 
of NMDA and other agents. INMDA was recorded at an am-
bient temperature of 23–25°C. 
1.4  Intracellular Ca2+ imaging 
For intracellular free Ca2+ imaging, Fluo-3/AM was used as 
fluorescent Ca2+ indicator. Fluo-3/AM was dissolved in 
DMSO with final work concentration of DMSO 0.1%. On 
DIV 11-12, the cultured hippocampal neurons were loaded 
with 5 mol L1 Fluo-3/AM for 45 min at 37°C in bath so-
lution. After being washed three times with new bath solu-
tion, the neurons were incubated at 37°C for another 30 min 
to complete deesterification of Fluo-3/AM. Intensity of flu-
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orescence with excitation wavelength at 485 nm and emis-
sion wavelength at 525 nm was recorded every 10 s for 5 
min using a laser scanning confocal microscope (TCS SP2, 
Leica Microsystems, Heidelberg, Germany). All image data 
were collected and analyzed with Leica control software of 
the microscope. The increase in intracellular free Ca2+ ([Ca2+]i) 
was determined according to the following equation: [Ca2+]i 
increase (%)=(F525Fbase,525)/Fbase,525×100, where F525 is the 
fluorescence intensity measured after each treatment, and 
Fbase,525 basal fluorescence intensity. 
1.5  Statistical analysis 
The software Clampfit 8.0 (Axon Instruments, Forster City, 
CA, USA) and SigmaPlot 2001 (Jandel Scientific, Costa 
Madre, CA, USA) were applied for data analysis and plot-
ting. All data are presented as mean±standard deviation. 
Data were analyzed with one-way ANOVA and post hoc 
Newman-Keuls test. Differences were considered statisti-
cally significant at a level of P<0.05. 
2  Results 
2.1  Dose dependent influence of glycine on high con-
centration NMDA-elicited currents 
To explore the influence of glycine on NMDA currents, the 
cultured hippocampal neurons were superfused with 300 
mol L1 NMDA containing different glycine concentration 
(0.03–10 mol L1), current responses (INMDA) were evoked 
by whole cell patch clamp recordings. All neurons for re-
cording were clamped near the resting potential in Mg2+-     
free extracellular solution. Peak current was reduced dose-     
dependently by glycine when the hippocampal neurons 
were exposed to 300 mol L1 NMDA (Figure 1), with the 
mean value of peak current being 0.62%±0.05%, 0.55%±    
0.05%, 0.48%±0.05% of control (NMDA alone) when gly-
cine was used at 1, 3, 10 mol L1 (P<0.01, Figure 1B), 
respectively. Examples of glycine effect on the peak current 
of INMDA were shown in Figure 1A with the use of 300 μmol 
L1 NMDA. It is suggested that glycine induces an inactiva-
tion of NMDARs when NMDA is used at 300 μmol L1. 
2.2  Inhibitory influence of glycine on 300 mol L1 
NMDA-elicited Ca2+ influx 
To verify the above results obtained with whole-cell re-
cording technique, we measured calcium accumulation 
changes in hippocampal neurons activated by 300 mol L1 
NMDA in the presence of 0.03–10 mol L1 glycine by free 
Ca2+ imaging. Identical to the results of INMDA recording 
shown in Figure 1, glycine decreased Ca2+ influx dose-      
dependently when 300 mol L1 NMDA was applied to the 
neurons (Figure 2A). With addition of NMDA at 300 μmol  
 
Figure 1  Dose-dependent effect of glycine on 300 mol L1 NMDA- 
activated peak current. A, Examples of glycine effect. B, Inhibitory effect 
of glycine on the peak current of INMDA elicited by 300 mol L1 NMDA 
(n=8). #, P<0.01, vs. control current elicited by 300 mol L1 NMDA  
without addition of glycine; *, P<0.01, vs. +Gly 0.03 mol L1. 
L1, the mean value of Ca2+ influx was decreased by glycine 
from 108.6%±7.8% of control (NMDA alone) to 55.3%±     
2.3% of glycine at 10 mol L1 (P<0.01, Figure 2B). We 
also found that the peak of [Ca2+]i induced by NMDA de-
creased in a dose-dependent fashion, similar to the mean 
value variation. Therefore, Ca2+ imaging results also indi-
cate that glycine induces an inactivation of NMDARs when 
NMDA is used at 300 mol L1. 
2.3  Zinc reverses the inhibitory effect of glycine on 300 
mol L1 NMDA-elicited receptor activity 
It is well known that the composition of the subunits of 
NMDARs will influence the function of the receptors. We 
therefore determined the expression of NR2 subunits on the 
cultured hippocampal neurons with immunofluorescent 
method. The hippocampal neurons we cultured expressed 
both NR2A and NR2B subunits of NMDARs on DIV 11-12 
(data not shown). To verify the involvement of NMDAR 
subunits, we used two inhibitors of NR2A and NR2B subu-
nits, Zn2+ and ifenprodil respectively [2]. As a result, in the 
presence of ZnCl2 (30 nmol L
1), an inhibitor of NR2A 
subunit, 300 mol L1 NMDA-elicited Ca2+ influx was ele- 
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Figure 2  Dose-dependent effect of glycine on 300 mol L1 
NMDA-elicited Ca2+ influx (n=20). A, Examples of glycine effect. B, 
Inhibitory effect of glycine on 300 mol L1 NMDA-elicited Ca2+ influx. #, 
P<0.01, vs. NMDA without addition of glycine; *, P<0.01, vs. +Gly 0.03  
mol L1. 
vated dose-dependently by glycine from 52.1%±4.1% at 
control (NMDA alone) to 92.9%±3.6% of glycine at 10 
mol L1 (P<0.01, Figure 3). However, in the presence of 
ifenprodil (10 mol L1), an inhibitor of NR2B subunit, 
NMDA-elicited Ca2+ influx were reduced, but glycine still 
dose-dependently reduced NMDAR responses induced by 
300 mol L1 NMDA, the mean value of Ca2+ influx was 
decreased by glycine from 66.4%±4.0% (NMDA with ifen-
prodil alone) to 47.1%±3.3% of glycine at 10 mol L1 
(P<0.01, Figure 4). Comparing the influence of glycine on 
NMDA-elicited Ca2+ influx with or without ifenprodil, there 
was only some difference in declining degree, but the de-
crease tendency was not reversed. Quantify the calcium 
influx changes of glycine inhibitory effects on NMDAR 
activity after use of ZnCl2 or ifenprodil, it was found that 
addition of ZnCl2 reversed the dose-dependent inhibitory 
effect of glycine on 300 mol L1 NMDA-induced Ca2+ 
influx, but ifenprodil did not change the tendency of inhibi-
tory influence of glycine on Ca2+ influx (Figure 5).  
Furthermore, we confirmed the reversal efficiency medi-
ated by zinc on the inhibitory effect of glycine at 300 mol 
L1 NMDA using whole cell recordings. As shown in Fig-
ure 6, glycine dose-dependently still reduced whole-cell 
currents elicited by 300 mol L1 NMDA with pretreatment 
of NR2B inhibitor, 10 mol L1 ifenprodil (Figure 6B), 
while 50 nmol L1 Zn2+ exerted notable different tendency 
on the glycine-dependent inhibition of NMDA currents, it  
 
Figure 3  Effect of glycine on 300 mol L1 NMDA-elicited Ca2+ influx 
in the presence of 30 nmol L1 ZnCl2 (n=20). A, Examples of glycine effect. 
B, Mean values of Ca2+ influx. #, P<0.01, vs. 300 mol L1 NMDA alone;  
*, P<0.01, vs. NMDA+Zn2+(30 nmol L1) without addition of glycine. 
 
Figure 4  Effect of glycine on 300 mol L1 NMDA-elicited Ca2+ influx 
in the presence of 10 mol L1 ifenprodil (n=20). A, Examples of glycine 
effect. B, Mean values of Ca2+ influx. #, P<0.01, vs. 300 mol L1 NMDA  
alone; *, P<0.01, vs. NMDA+ifenprodil without addition of glycine. 
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Figure 5  Dose-response curve of glycine on 300 mol L1 NMDA-elicited 
Ca2+ influx in the presence or absence of NMDAR inhibitor (n=20). A, 
ZnCl2, a NR2A blockor, was used at 30 nmol L
1. B, Ifenprodil, a NR2B  
inhibitor, was used at 10 mol L1. 
 
reversed the glycine dose dependent inhibition of INMDA 
(Figure 6A). Hence, NR2A subunit is potentially responsi-
ble for the glycine-dependent inactivation of NMDAR or is 
capable of modulating the glycine-dependent NMDAR in-
activation. 
3  Discussion 
NMDARs are a principal subtype of excitatory ligand-gated 
ion channel with prominent roles in physiological and dis-
ease processes in the central nervous system. Recognition 
that modulating mechanisms of NMDAR activity was pro-
foundly changed our understanding of chemical synaptic 
communication in the central nervous system. Ca2+-de-      
pendent inactivation is a reversible decrease in peak current 
which can be induced with a rise in extracellular Ca2+ con-
centration without agonist activation of the receptor itself. 
Desensitization is a decrease in the current response induced 
in the persistent presence of a glutamate site agonist 
[17–19]. Glycine-dependent inactivation, a new mechanism 
raised in our previous study, implies dual effects of glycine 
on NMDAR activation in hippocampal neurons via impact-
ing glycine binding site affinity of NMDARs [13].  
Up to now, molecular cloning of the cDNAs of individu-
al NMDAR subunits has distinctly indicated that function-
ally and pharmacologically distinct receptor subtypes could 
be generated from the different combinations of the NR1 
and NR2 subunit family [20]. Desensitization characteristics 
of NMDARs, which depends on the subunits expressed by 
the neurons, may be remarkably changed from one neuron 
to another. Accumulating evidence shows that there are 
subunit-specific differences in the desensitization properties 
of NMDARs [7,21]. The issue whether this glycine-        
dependent inactivation also appears in NMDAR complex 
composed of NR1 with other NR2 subunits remains to be 
elucidated. The study by Kendrick et al. has suggested that 
NR2A-like and NR2B-like NMDAR subtypes can exist 
within a single hippocampal neuron and can be selectively 
activated by altering the concentration of glycine [22]. In 
order to clarify these issues, we tested the glycine-dependent 
inactivation in the presence of NMDAR inhibitors, Zn2+ and 
ifenprodil respectively for NR2A and NR2B subunits [2,23]. 
The present study documented that blocking of NR2A sub-
unit by Zn2+ reversed the inhibitory effect of glycine on 300 
μmol L1 NMDA-induced NMDAR responses, but ifenpro-
dil, a NR2B subunit inhibitor, failed to change this type of 
inhibitory glycine effect. Our results suggested that NR2A 
subunit of NMDARs in hippocampal neurons was poten-
tially responsible for this glycine-dependent inactivation, 




Figure 6  Dose-dependent effect of glycine on 300 μmol L1 NMDA-elicited peak current (n=10). A, In the presence of NR2A inhibitor Zn2+ (ZnCl2, 50 
nmol L1). B, In the presence of NR2B inhibitor ifenprodil (10 μmol L1). *, P<0.05; **, P<0.01; ***, P<0.001, vs. Gly (glycine) 0 μmol L1. 
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NMDARs containing the NR2A subunit exhibit high af-
finity voltage-independent inhibition by Zn2+ [23]. The mo-
lecular determinants of high affinity zinc binding have been 
demonstrated to lie in the amino terminal domain of the 
NR2A subunit [24]. Studies of Gielen et al. [25] and Er-
reger et al. [26] suggest an allosteric interaction between 
Zn2+ and glutamate binding domains on NR2A. In other 
words, the affinity of zinc for its binding site is regulated by 
glutamate binding, thus causing desensitization or allosteric 
inhibition of NMDARs. Nahum-Levy et al. indicate an in-
fluence of small cations (not including Zn2+) on glutamate 
affinity but not glycine agonist affinity for NMDAR. Why 
could Zn2+ reverse the glycine-dependent inactivation of 
NMDAR activity, as shown in the present study? We as-
sumed that Zn2+ binding to NR2A subunit might cause an 
allosteric modulation of glycine site on NMDARs in addi-
tion to an influence on the glutamate binding site. Nong et 
al. show that glycine binding to its site on NMDARs prime 
but does not directly induce NMDAR internalization, and 
that subsequent application of NMDA or glutamate elicits 
NMDAR internalization and resultant reduction of NMDA 
currents [10]. Clathrin-dependent endocytosis of the 
NMDAR complex that was initiated by synaptic released 
glutamate in the presence of 100 μmol L1 glycine has also 
been proposed [27]. These reports inspire us to investigate 
the mechanism underlying the glycine-dependent inhibition 
of NMDAR activity.  
Modulation of the NMDAR response is an important 
mechanism for the physiological or pathophysiological 
consequences of NMDAR activation [28–30]. Concentra-
tions of glutamate, glycine or D-serine and many other fac-
tors (including Zn2+, Mg2+, H+, etc.) at the synaptic level of 
the neurons are important determinants of the ion current 
flowing through the NMDAR-gated ion channel. Recently, 
Takeda et al. report that Zn2+ promote NMDAR-dependent 
long-term potentiation (LTP) at hippocampal CA1 synapses 
[31,32]. Our present results may at least in part explain the 
underlying mechanism. Tetanic stimulation will greatly 
elevate the concentration of glutamate in the synaptic cleft, 
if glycine-dependent inactivation of NMDARs is accom-
plished through clathrin-dependent receptor internalization, 
NMDA currents will not be potentiated, and LTP will be 
inhibited. The presence of Zn2+, which is co-released with 
glutamate, will reverse this effect of glycine on NMDARs 
through inhibiting receptor internalization initiated by 
NMDAR activation which is induced by high level of glu-
tamate.  
In conclusion, the present study suggested that zinc could 
reverse glycine-dependent inactivation which occurred 
when NMDARs are activated by high concentrations of 
NMDA. This modulation of glycine inhibitory effect on 
NMDARs implies a novel approach to the regulation of 
synaptic plasticity in long-term potentiation, learning, and 
memory. 
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